Offer - Urjas Oil for just ₹ 1 X
Tagera 500 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Amebiasis. Tagera 500 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Tagera 500 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Tagera 500 Tablet include Vaginal itching, Vaginal discharge. Apart from the aforementioned side effects, Tagera 500 Tablet can also lead to other problems, which have been listed below. Such side effects of Tagera 500 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Tagera 500 Tablet's effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Tagera 500 Tablet related warnings talks about Tagera 500 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Anemia must refrain from the use of Tagera 500 Tablet since this can cause severe adverse effects. Other contraindications of Tagera 500 Tablet have been discussed in the sections ahead.
Additionally, Tagera 500 Tablet may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Tagera 500 Tablet is not safe while driving, and is is not addictive in nature.
Tagera 500 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Tagera 500 Tablet safe for pregnant women?
Tagera may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Tagera again without your doctor's advice.
Is the use of Tagera 500 Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Tagera. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Tagera 500 Tablet on the Kidneys?
Tagera rarely affects the kidneys.
What is the effect of Tagera 500 Tablet on the Liver?
Tagera has very mild side effects on the liver.
What is the effect of Tagera 500 Tablet on the Heart?
There are no any side effects of Tagera for the heart.
If you are suffering from any of the following diseases, you should not take Tagera 500 Tablet unless your doctor advises you to do so -
Is this Tagera 500 Tablet habit forming or addictive?
No, there is no any evidence that Tagera 500 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Tagera 500 Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Tagera 500 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Tagera 500 Tablet in mental disorders is not effective.
Interaction between Food and Tagera 500 Tablet
Taking Tagera 500 Tablet with food does not harm your health.
Interaction between Alcohol and Tagera 500 Tablet
Taking Tagera 500 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Solosec (secnidazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 839